UBISOFT ENTERTAINMENT (UBI.PA)

FR0000054470 - Common Stock

21.06  -0.05 (-0.24%)

Fundamental Rating

3

UBI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 39 industry peers in the Entertainment industry. UBI may be in some trouble as it scores bad on both profitability and health. UBI has a valuation in line with the averages, but on the other hand it scores bad on growth.



2

1. Profitability

1.1 Basic Checks

UBI had negative earnings in the past year.
UBI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: UBI reported negative net income in multiple years.
Each year in the past 5 years UBI had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -7.12%, UBI is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
With a Return On Equity value of -21.43%, UBI is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.12%
ROE -21.43%
ROIC N/A
ROA(3y)-2.29%
ROA(5y)-1.46%
ROE(3y)-7.6%
ROE(5y)-4.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

UBI has a better Gross Margin (88.35%) than 65.71% of its industry peers.
In the last couple of years the Gross Margin of UBI has remained more or less at the same level.
UBI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.53%
GM growth 5Y1.22%

3

2. Health

2.1 Basic Checks

UBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, UBI has more shares outstanding
The number of shares outstanding for UBI has been increased compared to 5 years ago.
Compared to 1 year ago, UBI has a worse debt to assets ratio.

2.2 Solvency

UBI has an Altman-Z score of 1.13. This is a bad value and indicates that UBI is not financially healthy and even has some risk of bankruptcy.
UBI's Altman-Z score of 1.13 is in line compared to the rest of the industry. UBI outperforms 57.14% of its industry peers.
The Debt to FCF ratio of UBI is 6.16, which is on the high side as it means it would take UBI, 6.16 years of fcf income to pay off all of its debts.
UBI has a Debt to FCF ratio (6.16) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.15 is on the high side and indicates that UBI has dependencies on debt financing.
UBI has a worse Debt to Equity ratio (1.15) than 65.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 6.16
Altman-Z 1.13
ROIC/WACCN/A
WACC5.73%

2.3 Liquidity

A Current Ratio of 1.51 indicates that UBI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.51, UBI is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
UBI has a Quick Ratio of 1.50. This is a normal value and indicates that UBI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of UBI (1.50) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.5

3

3. Growth

3.1 Past

The earnings per share for UBI have decreased strongly by -348.42% in the last year.
The Revenue has decreased by -8.84% in the past year.
The Revenue has been growing slightly by 0.93% on average over the past years.
EPS 1Y (TTM)-348.42%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q101.08%
Revenue 1Y (TTM)-8.84%
Revenue growth 3Y4.39%
Revenue growth 5Y0.93%
Revenue growth Q2Q14.33%

3.2 Future

Based on estimates for the next years, UBI will show a very strong growth in Earnings Per Share. The EPS will grow by 30.86% on average per year.
The Revenue is expected to grow by 2.20% on average over the next years.
EPS Next Y148.49%
EPS Next 2Y60.12%
EPS Next 3Y38.03%
EPS Next 5Y30.86%
Revenue Next Year11.73%
Revenue Next 2Y9.46%
Revenue Next 3Y8.31%
Revenue Next 5Y2.2%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

UBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
UBI is valuated reasonably with a Price/Forward Earnings ratio of 11.32.
71.43% of the companies in the same industry are more expensive than UBI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.26, UBI is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 11.32

4.2 Price Multiples

65.71% of the companies in the same industry are more expensive than UBI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, UBI is valued a bit cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.65
EV/EBITDA 4.56

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
UBI's earnings are expected to grow with 38.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.12%
EPS Next 3Y38.03%

0

5. Dividend

5.1 Amount

UBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UBISOFT ENTERTAINMENT

EPA:UBI (4/19/2024, 7:00:00 PM)

21.06

-0.05 (-0.24%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.68B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.32
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.12%
ROE -21.43%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 88.35%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.51
Quick Ratio 1.5
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-348.42%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y148.49%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-8.84%
Revenue growth 3Y4.39%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y